Cancer Family
Intestinal Neoplasm
CI-CAN-00000209Explore in graph →
Non-malignant1,893 active trials21 approved drugs383 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000209Explore in graph →
Clinical trials
9,158 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03323424 | Phase II Trial Assessing the Efficacy of Immuno-Radiation Abscopal Effect in Patients With Metastatic Cancers(IRAM) | withdrawn | Phase 2 | 0 | Institut de Cancérologie de la LoireOTHER | 1 | Jan 30, 2020 | clinicaltrials |
| NCT01741038 | AlloStim® In-Situ Vaccine in Pre-Treated Metastatic Colorectal Cancer | withdrawn | Phase 2 / Phase 3 | 0 | Mirror Biologics, Inc.INDUSTRY | 1 | Jan 22, 2020 |
| NCT03272659 | The Correlation of Surgical Colorectal Cancer Specimen Pathology With the Fluorescence of Photodynamic Diagnostics(PDD) | withdrawn | Phase 2 | 0 | Dr. Te VuongOTHER | 0 | Sep 18, 2019 | clinicaltrials |
| NCT03408561 | Social Media Listening in Improving Clinical Trial Recruitment in Patients With Cancer | withdrawn | N/A | 0 | University of Southern CaliforniaOTHER | 1 | Sep 17, 2019 | clinicaltrials |
| NCT03946033 | Impact of Immunoscore Colon Test on Adjuvant Therapeutic Strategy in Non-Metastatic Colon Cancer(PROSCORE) | withdrawn | N/A | 0 | UNICANCEROTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03161574 | FOLFOXIRI Chemotherapy Alone as Neoadjuvant Treatment for Circumferential Radial Margin (CRM) Positive Rectal Cancer | withdrawn | Phase 2 | 0 | Guangxi Medical UniversityOTHER | 1 | Aug 8, 2019 | clinicaltrials |
| NCT02309632 | Pancreatic Cancer Screening of High-Risk Individuals in Arkansas | withdrawn | N/A | 0 | University of ArkansasOTHER | 1 | Jul 29, 2019 | clinicaltrials |
| NCT02422680 | Patient Satisfaction With Colonoscopy in a Danish Setting - What Are the Most Important Factors? | withdrawn | — | 0 | Aalborg University HospitalOTHER | 1 | Jul 5, 2019 | clinicaltrials |
| NCT03532204 | Oligometastases of the LIVer Treated With Chemotherapy With ou Without Extracranial Stereotactic Body Radiation Therapy in Patients With Colorectal Cancer(OLIVER) | withdrawn | N/A | 0 | UNICANCEROTHER | 0 | May 22, 2019 | clinicaltrials |
| NCT00835055 | Expression of Molecular Markers Before and After Neo-adjuvant Chemoradiotherapy in Rectal Cancer | withdrawn | — | 0 | St. Claraspital AGOTHER | 1 | Apr 5, 2019 | clinicaltrials |
| NCT03717038 | Sym004 Versus TAS-102 in Patients With mCRC | withdrawn | Phase 3 | 0 | Symphogen A/SINDUSTRY | 0 | Feb 4, 2019 | clinicaltrials |
| NCT00651677 | Hand Assisted Versus "Pure" Laparoscopic Assisted Proctectomy for Rectal Cancer | withdrawn | N/A | 0 | Weill Medical College of Cornell UniversityOTHER | 1 | Jan 14, 2019 | clinicaltrials |
| NCT00621036 | Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma | withdrawn | Phase 2 | 0 | University of Texas Southwestern Medical CenterOTHER | 1 | Nov 26, 2018 | clinicaltrials |
| NCT00005030 | SCH 66336 Before Surgery in Treating Patients With Colorectal Cancer That Has Metastasized to the Liver | withdrawn | Phase 1 | 0 | M.D. Anderson Cancer CenterOTHER | 0 | Nov 14, 2018 | clinicaltrials |
| NCT03493009 | Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System | withdrawn | N/A | 0 | Motus GI Medical Technologies LtdINDUSTRY | 0 | Oct 31, 2018 | clinicaltrials |
| NCT03340558 | Atezolizumab Monotherapy vs Atezolizumab Plus Cobimetinib in Liver Metastases From Colorectal Cancer(ATELIER) | withdrawn | Phase 2 | 0 | Niharika MettuOTHER | 1 | Oct 9, 2018 | clinicaltrials |
| NCT03014284 | Novel Listeria Vectors Secreting Gut Flora-Altering Agents to Prevent Colon Cancer and Treat Colitis | withdrawn | — | 0 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT03232814 | Walk on: A Community-based Approach to Increase Physical Activity Among Men Treated for Colorectal Cancer | withdrawn | N/A | 0 | University of OttawaOTHER | 1 | Sep 17, 2018 | clinicaltrials |
| NCT03096899 | A Study to Estimate Overall Survival in Patients Receiving Best Supportive Care for Treatment-Resistant, Metastatic Colorectal Carcinoma | withdrawn | — | 0 | The Rogosin InstituteOTHER | 1 | Aug 31, 2018 | clinicaltrials |
| NCT03182894 | Epacadostat in Combination With Pembrolizumab and Azacitidine in Subjects With Metastatic Colorectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | James J LeeOTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT02504411 | Outcomes of Disposable Distal Attachment Device (Endocuff and Transparent Plastic Cap) Assisted Colonoscopy | withdrawn | N/A | 0 | The University of Texas Health Science Center, HoustonOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00577109 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer. | withdrawn | Phase 2 | 0 | Hoffmann-La RocheINDUSTRY | 1 | Jul 31, 2018 | clinicaltrials |
| NCT03306966 | Assessing the Safety and Performance of the Endoscopic Linear Cutter Stapler and Reloads (Frankenman) in Colectomy | withdrawn | — | 0 | DuomedINDUSTRY | 0 | Jun 1, 2018 | clinicaltrials |
| NCT03222089 | Phase II Trial of FOLFOXIGIL Versus FOLFOXIRI as First-line Therapy in Patients With mCRC | withdrawn | Phase 2 | 0 | Fujian Cancer HospitalOTHER_GOV | 1 | Mar 27, 2018 | clinicaltrials |
| NCT01919541 | Mechanistic Prehabilitation | withdrawn | N/A | 0 | Franco CarliOTHER | 1 | Mar 22, 2018 | clinicaltrials |
| NCT03307603 | Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer | withdrawn | Phase 1 / Phase 2 | 0 | Case Comprehensive Cancer CenterOTHER | 0 | Feb 27, 2018 | clinicaltrials |
| NCT01710293 | Intervention Protocol for Automated Point-of-Care Surveillance of Outpatient Delays in Cancer Diagnosis(PACT CREATE 3) | withdrawn | N/A | 0 | VA Office of Research and DevelopmentFED | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00388700 | A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer | withdrawn | Phase 2 | 0 | Galectin Therapeutics Inc.INDUSTRY | 1 | Feb 14, 2018 | clinicaltrials |
| NCT02630420 | Cetuximab and Savolitinib Treatment of Ras Wild-Type Colorectal Cancer | withdrawn | Phase 1 | 0 | Yale UniversityOTHER | 0 | Oct 26, 2017 | clinicaltrials |
| NCT02774512 | Predictive Biomarkers of Biological Activity and Efficacy of Nilotinib on ZAK Target in Non-metastatic Colon Cancer(ZAK-0) | withdrawn | Early Phase 1 | 0 | Institut BergoniéOTHER | 1 | Oct 6, 2017 | clinicaltrials |
| NCT03007771 | Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia | withdrawn | Phase 1 | 0 | Washington University School of MedicineOTHER | 0 | Oct 6, 2017 | clinicaltrials |
| NCT02542436 | Avastin (Bevacizumab) in the Treatment of Metastatic Colorectal Cancer in Normal Clinical Use in the UK Population | withdrawn | — | 0 | Hoffmann-La RocheINDUSTRY | 0 | Sep 13, 2017 | clinicaltrials |
| NCT03264274 | Trial of Aflibercept Monotherapy With DCE-US in Chemorefractory Metastatic Colorectal Cancer(AUSCOR) | withdrawn | Phase 2 | 0 | Barts & The London NHS TrustOTHER | 0 | Aug 31, 2017 | clinicaltrials |
| NCT02345746 | Hepatic Arterial Infusion With FOLFOX Alone or in Combination With IV Chemotherapy in Colon Cancer With Liver Metastasis | withdrawn | Phase 2 | 0 | Western Regional Medical CenterOTHER | 0 | Aug 24, 2017 | clinicaltrials |
| NCT00002664 | Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | James AhlgrenOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01095523 | Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01176500 | A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors | withdrawn | Phase 1 / Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01386502 | CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors | withdrawn | Phase 1 | 0 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT01936961 | Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors(I-CREST) | withdrawn | N/A | 0 | Western Regional Medical CenterOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT03191487 | Evaluation of a New Organization for Collecting Pre-chemotherapy Session Information(ChimioPal) | withdrawn | N/A | 0 | Centre Hospitalier Universitaire de NīmesOTHER | 1 | Jun 19, 2017 | clinicaltrials |
| NCT00408772 | Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer | withdrawn | Phase 2 | 0 | University of California, DavisOTHER | 1 | Jun 9, 2017 | clinicaltrials |
| NCT01646554 | Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases(BOS3) | withdrawn | Phase 2 / Phase 3 | 0 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | May 9, 2017 | clinicaltrials |
| NCT02413853 | Combination Chemotherapy and Bevacizumab With or Without PRI-724 in Treating Patients With Newly Diagnosed Metastatic Colorectal Cancer(PRIMIER) | withdrawn | Phase 2 | 0 | University of Southern CaliforniaOTHER | 1 | Apr 17, 2017 | clinicaltrials |
| NCT01270438 | Combination Chemotherapy and Bevacizumab With or Without RO4929097 in Treating Patients With Metastatic Colorectal Cancer | withdrawn | Phase 2 | 0 | National Cancer Institute (NCI)NIH | 1 | Apr 4, 2017 | clinicaltrials |
| NCT02857608 | A Prospective, Open-Label, Multi-center Comparison of Lymphoseek Identified Lymph Nodes and Clinically Identified Lymph Nodes of Subjects With Known Cancer of the Anus | withdrawn | Phase 2 | 0 | Cardinal Health 414, LLCINDUSTRY | 0 | Mar 15, 2017 | clinicaltrials |
| NCT01032590 | Internet-Based Weight-Loss Program for Colorectal Cancer Survivors | withdrawn | N/A | 0 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 6, 2017 | clinicaltrials |
| NCT00510627 | Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases(Prometheus) | withdrawn | Phase 4 | 0 | Boston Scientific CorporationINDUSTRY | 1 | Mar 3, 2017 | clinicaltrials |
| NCT02423174 | Eval. of Safety and Effectiveness of the FMwand Ferromagnetic Surgical System During Total Mesorectal Excision Surgery | withdrawn | — | 0 | Domain Surgical, Inc.INDUSTRY | 0 | Feb 10, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Jan 30, 2020source: clinicaltrials